DEF 14A Filing

Company

Anixa Biosciences Inc

Filed

February 6, 2025

Period of Report

October 31, 2024

Accession Number

0001493152-25-005199

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →